Generally, patients with heterozygous gain-of-function variants can develop DCM phenotype with desmin deficiency, meanwhile, HCM with desmin-overload has been determined in patients with homozygous loss-of-function variants. This evidence concerns the gene DES and hyperinsulinemic hypoglycemia, familial, 4.